Madrigal Pharmaceuticals Inc
(MDGL)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -241,846 | -177,297 | -114,197 | -52,546 | -202,244 |
| Depreciation Amortization | 405 | 299 | 202 | 113 | 471 |
| Accounts payable and accrued liabilities | 20,363 | 9,401 | 50 | 3,379 | -161 |
| Other Working Capital | 30,651 | 20,615 | 9,410 | 2,908 | 23,482 |
| Other Operating Activity | 6,510 | 11,116 | 14,225 | 2,717 | 20,891 |
| Operating Cash Flow | $-183,917 | $-135,866 | $-90,310 | $-43,429 | $-157,561 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -4,846 | -20,602 | -60,743 | -33,420 | 160,114 |
| PPE Investments | -209 | -96 | -46 | -44 | -334 |
| Investing Cash Flow | $-5,055 | $-20,698 | $-60,789 | $-33,464 | $159,780 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,030 | 0 | 0 | 478 | N/A |
| Common Stock Issued | 170,207 | 151,734 | 130,635 | 66,616 | 5,088 |
| Financing Cash Flow | $171,237 | $151,734 | $130,635 | $67,094 | $5,088 |
| Beginning Cash Position | 54,004 | 54,004 | 54,004 | 54,004 | 46,697 |
| End Cash Position | 36,269 | 49,174 | 33,540 | 44,205 | 54,004 |
| Net Cash Flow | $-17,735 | $-4,830 | $-20,464 | $-9,799 | $7,307 |
| Free Cash Flow | |||||
| Operating Cash Flow | -183,917 | -135,866 | -90,310 | -43,429 | -157,561 |
| Capital Expenditure | -209 | -96 | -46 | -44 | -334 |
| Free Cash Flow | -184,126 | -135,962 | -90,356 | -43,473 | -157,895 |